Deep Learning on Hyperspectral Pathology for Recurrence Prediction in Clear Cell Renal Cell Carcinoma
HSI with deep learning accurately identifies recurrent ccRCC and reveals molecular-metabolic signatures, supporting precision postoperative risk stratification.
Authors
- Zhengyang Zhang
- Weidong Tian (ORCID: https://orcid.org/0000-0003-0175-1132)
- Jianning Wang (ORCID: https://orcid.org/0000-0003-2278-7660)
- Xiumei Shao (ORCID: https://orcid.org/0000-0002-2528-0454)
- Xulei Wang
- Yihui He
- Yihan Zhao
- Yunchao Wang
Institutions
- Shandong University (CN)
- The Fourth People's Hospital of Zibo City (CN)
- Central Hospital of Zibo (CN)
- Shandong Provincial QianFoShan Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Journal of Biophotonics
- Published
- 2025-12-14
- DOI
- https://doi.org/10.1002/jbio.202500546
- Primary Topic
- AI in cancer detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province